Meta-analysis reaffirms safety, efficacy of intermittent biologic use
According to a recent meta-analysis, patients who stop and restart biologic treatment can regain psoriasis control without experiencing unexpected safety issues.
Related Articles
Addressing Research Gaps in the AAD AD Guidelines
David Rosmarin, MD, addresses the research gaps in recommendations for systemic therapies in atopic dermatitis in the latest guidelines.
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
Interim findings from the PROSPER study of mogamulizumab in adults with CTCL were recently presented orally.
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates
Five experts delved into the latest updates to treatment guidelines and the updated label use for dupilumab for hand-foot AD.
Reviewing the Rosacea Pipeline: A Look at the Last 10 Years
In recognition of Rosacea Awareness Month, Dermatology Times is reviewing research and strides in rosacea treatment over the last decade.
Is Your Texting as Caring as Your Bedside Manner?
Test your knowledge to see if your patients would consider you an efficient texter.
Dermatology Residency Programs Lack Specific, Comprehensive Education on Sensitive Skin
Research from the GW School of Medicine and Health Sciences was recently published in the Journal of Drugs in Dermatology.
Partner Q&A: Spherix Global Insights’ Role in Shaping the Future of Dermatology
Dermatology Times is pleased to introduce one of our newest partners, Spherix Global Insights. Learn more about their vision and plans to leverage knowledge to…
My Colleague Has Defamed Me Online: What Can I Do?
What are your rights in the instance a colleague defames you online or on social media? David Goldberg, MD, JD, shares legal advice in our…
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know
The FDA has released guidelines for clinicians and tips to identify the distinguishing features of counterfeit products.
QUIZ: Test Your Knowledge of Rosacea Complications and Comorbidities
Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.